hydrolysis, polarity, and their crystalline nature. Taken
collectively, these attributes have allowed sultams to emerge
as privileged structures in drug discovery.
sultam building blocks 13 and 15. All subsequent reactions
leading to more complex building blocks are achieved with
high levels of diastereoselectivity to afford enantiopure
δ-sultams in good yields (Schemes 2–5).
Traditionally, sultam synthesis has relied on classical
cyclization protocols such as Pictet-Spengler,8 Friedel-
Crafts,9 dianion,10 cyclization of aminosulfonyl chlorides,11
[3 + 2] cycloadditions,12 and Diels-Alder reactions.13
Recently, however, a number of transition-metal-catalyzed
approaches to sultams have come to light, including the use
of Pd-,14 Au-,15 Cu-,16 and Rh-catalyzed cyclizations.17
Moreover, RCM has been reported to generate several
interesting sulfur-containing heterocycles with biological
potential.2,18 Our continuous interest in the development of
transition-metal-catalyzed approaches to sulfur and phos-
phorus heterocycles (S- and P-heterocycles)18 has prompt
us to investigate an RCM approach for the synthesis of chiral,
nonracemic sultams. The method is designed to afford
sultams containing multiple handles as attractive scaffolds
for potential library production with the ultimate goal of
Our approach began with the multigram production of
allylsulfonyl chloride (7).19 Subsequent amination with anhy-
drous NH3, following the procedure reported by Belous and
co-workers, afforded sulfonamide 8 in good yields.19 Mono-
protection with Boc2O20 afforded sulfonamide 9 (93%), pos-
sessing an acidic proton (N-H) suitable for Mitsunobu alky-
lation (Scheme 1). Mitsunobu reaction with chiral, nonracemic
alcohol 11, derived from epoxide 10 using the Christie proto-
col,21 afforded the RCM precursor 12 in good yield (78%).
Initial attempts to obtain 13 via RCM using the second-
generation Grubbs catalyst22 in refluxing CH2Cl2 or DCE were
unsuccessful. Subsequent RCM studies revealed that 13 could
be obtained in good yield when toluene was used as the solvent
under refluxing conditions. Alternatively, Boc-removal in diene
12 using TFA, followed by RCM in refluxing CH2Cl2, afforded
the δ-sultam 15 in excellent yield.23
Scheme 1. RCM Strategy to Sultams 13 and 15
Scheme 2. Facile Route to γ-Hydroxy Sultam 18
The diastereoselective route to the desired δ-sultam 18
continued with dihydroxylation of cyclized products 13 and
15 (Scheme 2). When sultam 15 (R ) H) was first subjected
uncovering interesting biological leads. The method we
herein report utilizes a key Mitsunobu alkylation reaction to
install a stereogenic center at C3 (Scheme 1). Ensuing
metathesis is used as the cyclization event to yield key allyl
(14) (a) Merten, S.; Fro¨hlich, R.; Kataeva, O. AdV. Synth. Catal. 2005,
347, 754–758. (b) Vasudevan, A.; Tseng, P-S.; Djuric, S. W. Tetrahedron
Lett. 2006, 47, 8591–8593.
(8) Silvestri, R.; Marfe`, G.; Artico, M.; La Regina, G.; Lavecchia, A.;
Novellino, E.; Morgante, M.; Di Stefano, C.; Catalano, G.; Filomeni, G.;
Abruzzese, E.; Ciriolo, M. R.; Russo, M. A.; Amadori, S.; Cirilli, R.; La
Torre, F.; Salimei, P. S. J. Med. Chem. 2006, 49, 5840–5844.
(9) (a) Bravo, R. D.; Ca´nepa, A. S. Synth. Commun. 2002, 32, 3675–
3680. (b) Orazi, O. O.; Corral, R. A.; Bravo, R. J. Heterocycl. Chem. 1986,
23, 1701–1708. (c) Katritzky, A. R.; Wu, J.; Rachwal, S.; Rachwal, B.;
Macomber, D. W.; Smith, T. P. Org. Prep. Proced. Int. 1992, 24, 463–467.
(10) Lee, J.; Zhong, Y.-L.; Reamer, R. A.; Askin, D. Org. Lett. 2003,
5, 4175–4177.
(15) Liu, X.-Y.; Li, C.-H.; Che, C.-M. Org. Lett. 2006, 8, 2707–2710.
(16) (a) Dauban, P.; Dodd, R. H. Org. Lett. 2000, 2, 2327–2329. (b)
Dauban, P.; Sanie`re, L.; Aure´lie, T.; Dodd, R. H. J. Am. Chem. Soc. 2001,
123, 7707–7708. (c) Sherman, E. S.; Chemler, S. R.; Tan, T. B.; Gerlits,
O. Org. Lett. 2004, 6, 1573–1575. (d) Zeng, W.; Chemler, S. R. J. Am.
Chem. Soc. 2007, 129, 12948–12949.
(17) (a) Liang, J.-L.; Yuan, S.-X.; Chan, P. W. H.; Che, C.-M. Org.
Lett. 2002, 4, 4507–4510. (b) Padwa, A.; Flick, A. C.; Leverett, C. A.;
Stengel, T. J. Org. Chem. 2004, 69, 6377–6386.
(18) (a) McReynolds, M. D.; Dougherty, J. M.; Hanson, P. R. Chem.
ReV. 2004, 104, 2239–2258. (b) Moriggi, J.-M.; Brown, L. J.; Castro, J. L.;
Brown, R. C. D. Org. Biomol. Chem. 2004, 2, 835–844. (c) Freitag, D.;
Schwab, P.; Metz, P. Tetrahedron Lett. 2004, 45, 3589–3592. (d) Karsch,
S.; Freitag, D.; Schwab, P.; Metz, P. Synthesis 2004, 10, 1696–1712.
(19) Belous, M. A.; Postovsky, I. Y. J. Gen. Chem. USSR 1950, 20,
1761–1770.
(11) Enders, D.; Moll, A.; Bats, J. W. Eur. J. Org. Chem. 2006, 1271–
1274.
(12) Chiacchio, U.; Corsaro, A.; Rescifina, A.; Bkaithan, M.; Grassi,
G.; Piperno, A. Tetrahedron 2001, 57, 3425–3433.
(13) (a) Metz, P.; Seng, D.; Fro¨hlich, R. Synlett 1996, 741–742. (b)
Plietker, B.; Seng, D.; Fro¨hlich, R.; Metz, P. Tetrahedron 2000, 56, 873–
879. (c) Rogatchov, V. O.; Bernsmann, H.; Schwab, P.; Fro¨hlich, R.;
Wibbeling, B.; Metz, P. Tetrahedron Lett. 2002, 43, 4753–4756. (d) Greig,
I. R.; Trozer, M. J.; Wright, P. T. Org. Lett. 2001, 3, 369–371. (e) Wanner,
J.; Harned, A. M.; Probst, D. A.; Poon, K. W. C.; Klein, T. A.; Snelgrove,
K. A.; Hanson, P. R. Tetrahedron Lett. 2002, 43, 917–921.
(20) Neustadt, B. R. Tetrahedron Lett. 1994, 35, 379–380.
(21) Davoille, R. J.; Rutherford, D. T.; Christie, S. D. R. Tetrahedron
Lett. 2000, 41, 1255–1259.
(22) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999,
1, 953–956.
2224
Org. Lett., Vol. 10, No. 11, 2008